Hjem › Interstitielle lungesykdommer › Utah › Salt Lake City
Kliniske studier for Interstitielle lungesykdommer i Salt Lake City, UT
9 studier for Interstitielle lungesykdommer søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
- University of Utah Health Sciences Center, Salt Lake City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 3
- USA025, Salt Lake City
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekruttererFase 3
- GSK Investigational Site, Salt Lake City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- University of Utah, Salt Lake City
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
- University of Utah, Salt Lake City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererObservasjonsstudie
- University of Utah Health, Salt Lake City
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RekruttererObservasjonsstudie
- University of Utah, Salt Lake City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekruttererFase 3
- University of Utah Health, Salt Lake City
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekruttererFase 2
- aTyr Investigative Site, Salt Lake City
Interstitielle lungesykdommer-studier i andre byer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Charleston, SC13 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Aurora, CO11 studier
- Ann Arbor, MI11 studier
- Dallas, TX9 studier
- Boston, MA9 studier
Andre studier i Salt Lake City
- Ikke-småcellet lungekreft31 studier
- Kreft (alle typer)27 studier
- Brystkreft27 studier
- Kolorektal kreft22 studier
- Lungekreft21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastatisk kreft20 studier
- Eggstokkreft19 studier
- Fedme18 studier
- Akut myelogen leukemi17 studier
- Hjertesvikt17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.